Backed by Microsoft’s Leader ranking in the Forrester Wave™ for Low-Code Platforms (Q2 2025), Exeevo gives CIOs control, speed, and scalability—without tech debt.

The Everything Platform Is Coming — Are You Ready?

Enterprise software is undergoing a structural shift, and CIOs are at the epicenter.

Low-code adoption has surged, with most developers now using it for a majority of their application development. But the game is no longer just about speed or simplification. As AI becomes embedded across the software development lifecycle (SDLC)—from intelligent agents to TuringBots—low-code platforms are evolving into something bigger: AppGen platforms that generate, adapt, and automate enterprise solutions with unprecedented agility.

According to Forrester’s Q2 2025 Wave for Low-Code Platforms for Professional Developers, this next-generation platform model will depend on:

  • Core capabilities like data modeling, UX, digital process automation (DPA), and developer governance.
  • Rapidly evolving AI tools that extend far beyond productivity enhancements.
  • Federated operating models that engage not just IT but also business users and citizen developers.

In short: this is no longer about niche tooling—it’s about building your enterprise software strategy around a foundational platform.

That’s why Microsoft’s leadership position in the Forrester Wave™ matters. And that’s why Exeevo—built entirely on Microsoft’s low-code stack—is uniquely positioned to support CIOs in life sciences as they embrace this shift.

The Forrester Wave. Low Code Platforms for Professional Developers. Microsoft scoops #1

A strategic advantage for CIOs under pressure

Today’s CIOs in pharmaceutical and medtech organizations are navigating a complex maze: increasing compliance requirements, decentralized data, demand for omnichannel engagement, and relentless pressure to deliver faster—without increasing IT headcount.

In this context, low-code platforms offer the promise of agility, speed, and scale. But not all platforms are created equal.

That’s why the recent Forrester Wave™ for Low-Code Platforms for Professional Developers (Q2 2025) is so significant. Microsoft has been named a Leader, and that’s great news for CIOs using—or considering—Exeevo.

Microsoft named a leader in low-code by Forrester

According to Forrester, Microsoft earned top marks out of 13 competitors for:

  • Integration and extensibility
  • Governance and security
  • Tooling for professional developers
  • Cloud-native scalability

These are precisely the attributes CIOs prioritize when choosing platforms that must support global deployments, multitenant compliance, and integration with enterprise infrastructure.

Exeevo: purpose-built for Life Sciences on Microsoft’s foundation

Exeevo’s CRM and engagement suite for life sciences is fully built on Microsoft’s cloud and low-code stack—including Azure, Power Platform, and Dynamics 365.

Here’s what that means for CIOs:

ChallengeExeevo on Microsoft Delivers
Long deployment timesRapid configuration and deployment using Microsoft’s low-code environment
Limited developer resourcesLeverage citizen development + IT oversight for scalability
System integration chaosNative compatibility with Teams, Outlook, SharePoint, Dynamics, Azure AD
Data compliance & riskMicrosoft’s security, compliance, and audit controls built-in
Global rolloutsMultilingual, role-based access with unified governance

Reduce IT Burden, Not Control

With Exeevo’s Microsoft-native approach, IT teams maintain control over data policies, user access, integration standards, and workflow governance—all while enabling faster time-to-value for business teams.

You can empower commercial operations, medical affairs, and marketing to self-serve with confidence—without the risk of shadow IT.

No New Stack. No New Headaches.

Choosing a CRM platform built on Microsoft’s low-code ecosystem means your teams work with tools they already know—no steep learning curves, no duplicate systems, no IT drain.

Exeevo fits into your Microsoft architecture—not alongside or against it. You don’t need to rethink your digital foundation to support new customer engagement demands.

Future-Proofing without Technical Debt

As AI, data, and regulatory requirements evolve, Exeevo ensures your core engagement platform keeps up without rewrites or forklift upgrades. Microsoft’s ongoing platform investments and roadmap translate into continuous value for your business.

And because Exeevo inherits Microsoft’s scalability, you’re ready for growth across markets, use cases, and users.

Proven in Practice: How Life Sciences Leaders Use Exeevo + Microsoft

Across the pharmaceutical and medtech landscape, CIOs are already leveraging Exeevo’s Microsoft-native platform to transform customer engagement—without reengineering their enterprise stack.

Here are a few examples:

  • A top-20 global pharmaceutical company used Exeevo to unify its medical and commercial engagement across 40+ markets. With Microsoft Power Platform under the hood, local teams rapidly customized compliant workflows—without waiting on global IT cycles.
  • A fast-growing specialty medtech firm integrated Exeevo’s CRM with Microsoft Teams, enabling field reps to collaborate with medical affairs in real time. The result: faster HCP response times and greater insight into patient journeys.
  • A leading biopharma streamlined omnichannel orchestration by aligning Exeevo with their Microsoft 365 and Azure ecosystems. This eliminated redundant tools, simplified governance, and reduced CRM-related support tickets by over 30%.

These success stories share a common thread: speed, security, and scalability—delivered without tech debt.

Final Word: Innovation You Can Trust

The Forrester Wave makes it clear: Microsoft is leading in low-code for professional developers.

At Exeevo, we’re proud to be the only life sciences engagement platform that deeply leverages this advantage—so CIOs don’t have to choose between agility and control.

Ready to learn how Exeevo and Microsoft can modernize your field engagement and medical CRM strategy—without creating tech debt? Schedule a strategy session